Gender bias in therapeutic effort: from research to health care.
In conclusion, health professionals frequently attribute physical symptoms to women's emotionality, influencing their greater prescription of symptomatic drugs. Whether the same reason influences the lower prescription of therapeutic drugs in women than in men should be analyzed. There are biological determinants to consider due to their influence on a greater pharmacological toxicity in women. Clinical trials should improve according to the gender recommendations by the Food and Drugs Administration.
PMID: 32452310 [PubMed - in process]
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Ruiz-Cantero MT, Blasco-Blasco M, Chilet-Rosell E, Peiró AM Tags: Farm Hosp Source Type: research
More News: Allergy & Immunology | Ankylosing Spondylitis | Cholesterol | Clinical Trials | Drugs & Pharmacology | Genetics | Health Management | Liver | Pain | Statin Therapy | Toxicology | Urology & Nephrology | Women